Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00223769 · ClinicalTrials.gov registry record · NA

The Use of Anabolic Steroids to Improve Function After Spinal Cord Injury

A NA study, sponsored by US Department of Veterans Affairs.

Completed
Registry status
NA
Development phase
40
Enrollment target

NCT00223769 is a NA study that has completed, run by US Department of Veterans Affairs. The registered enrollment target is 40 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00223769, a NA study, has completed, sponsored by US Department of Veterans Affairs.

COMPLETED
Registry status
NA
Development phase
40 participants
Enrollment target

Study Summary

The purpose of this study is to determine the effect of oxandrolone on the function and quality of life of patients with chronic spinal cord injury.

Interventions

  • DRUG Oxandrolone

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2004-01
Est. Completion 2006-05
Phase NA

Sponsor

US Department of Veterans Affairs

632 total trials

What the Registry Record Tells You About NCT00223769

The ClinicalTrials.gov registry entry for NCT00223769 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is US Department of Veterans Affairs, which has 632 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Oxandrolone is the first listed.

NCT00223769 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00223769 about?

NCT00223769 is a clinical study titled "The Use of Anabolic Steroids to Improve Function After Spinal Cord Injury". The purpose of this study is to determine the effect of oxandrolone on the function and quality of life of patients with chronic spinal cord injury.

What is the current status of trial NCT00223769?

This trial is currently completed. It is a NA study. The enrollment target is 40 participants. The study started on 2004-01. Estimated completion is 2006-05.

What interventions are being tested in trial NCT00223769?

The interventions under investigation include: Oxandrolone (DRUG).

Who is sponsoring clinical trial NCT00223769?

This trial is sponsored by US Department of Veterans Affairs, which has 632 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.